fbpx
Select Page
CSL Behring announcement on their product Zemaira

CSL Behring announcement on their product Zemaira

Today, the Alpha-1 Foundation received the following communication from CSL Behring, regarding Zemaira®, their prescription drug for augmentation therapy for the treatment of Alpha-1 Antitrypsin Deficiency (Alpha-1). “The Alpha-1 Foundation is committed to provide...